HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

Home Local Data New Jersey

Local Data: New Jersey

There are approximately 47,200 people living with Hepatitis C in New Jersey.

New Jersey

Hepatitis C Prevalence

Estimated number of people living with Hepatitis C, 2013-2016 47,200

Estimated rate of people living with Hepatitis C per 100,000 population, 2013-2016 680

Estimated percent of people living with Hepatitis C, by Sex, 2013-2016

69.6% 30.4%
  • Male
  • Female

Estimated percent of people living with Hepatitis C, by Race/Ethnicity, 2013-2016

31.0% 69.0%
  • Black
  • Non-Black

Estimated percent of people living with Hepatitis C, by Age, 2013-2016

3.7% 66.7% 29.6%
  • Less than 50
  • 50-74 (Baby Boomer)
  • 75 and above

Estimated rate of people living with Hepatitis C per 100,000 population, by Geography, 2013-2016

1000 800 600 400 200 0 680.0 State 776.6 Region 926.5 United States

Hepatitis C Mortality

Number of deaths related to Hepatitis C, 2017 342

Rate of deaths related to Hepatitis C per 100,000 population, 2017 4

Percent of deaths of people related to Hepatitis C, by Sex, 2017

69.0% 31.0%
  • Male
  • Female

Percent of deaths of people related to Hepatitis C, by Race/Ethnicity, 2017

16.1% 29.8% 52.6% 1.5%
  • American Indian or Alaska Native, Asian or Pacific Islander, or Hispanic/Latinx
  • Black
  • White
  • Data suppressed or not available

Percent of deaths of people related to Hepatitis C, by Age, 2017

2.9% 81.9% 8.2% 7.0%
  • Less than 50
  • 50-74 (Baby Boomer)
  • 75 and above
  • Data suppressed or not available

Number of deaths related to Hepatitis C, 2013-2017

2013 2014 2015 2016 2017 300 400 500 424 446 400 378 342

Rate of deaths related to Hepatitis C per 100,000 population, by Geography, 2017

10 8 6 4 2 0 4.0 State 3.9 Region 5.3 United States

Demographics, 2017

Total Population 9,005,644

State Population By Age

  • Less than 50 (63.5%)
  • 50-74 (Baby Boomer) (29.7%)
  • 75 and above (6.8%)

Hepatitis C, by Age

Estimated Percent of People Living with Hepatitis C, by Age, 2013-2016

Percent of Deaths Related to Hepatitis C, by Age, 2017

  • Less than 50
  • 50-74 (Baby Boomer)
  • 75 and above
  • Data suppressed or not available

Opioid Indicators

Opioid Prescription Rate, 2020 31.8

Pain Reliever Misuse Percent, 2019-2020 3.2

Social Determinants of Health, 2018

  • State
  • Region
  • United States
89.3% 88.8% 87.5%

Percent of Population with a High School Education, 2018

0.481 0.492 0.481

Income Inequality (Gini Coefficient), 2018

10.4% 12.5% 14.0%

Percent of Population Living in Poverty, 2018

$76,212 $64,974 $59,039

Median Household Income, 2018

9.2% 6.8% 8.6%

Percent of Population Lacking Health Insurance, 2018

Viral Hepatitis Treatment Restrictions

Prior Authorization

State Medicaid programs may require patients to receive prior authorization in order to receive treatment for Hepatitis C.

PA Required PA Removed

Fibrosis Level Treatment Restrictions

State Medicaid programs may require a patient to reach a certain stage of fibrosis (liver scarring) before being able to access treatment for Hepatitis C.

F3 F2 F1 No Restrictions

Substance Use Treatment Restrictions

State Medicaid programs may require a period of abstinence from drugs or alcohol prior to or during treatment or require providers to counsel their patients regarding drug or alcohol use before being able to access treatment for Hepatitis C.

6 Months 3 Months Abstinence Screening and Counseling No Restrictions

Prescriber Treatment Restrictions

State Medicaid programs may require training or for a specialist to be involved for a prescription for Hepatitis C treatment.

By or in Consultation with Specialist Prescriber Training or Certification No Restrictions

Retreatment Restrictions

State Medicaid programs may require more severe restrictions for patients seeking retreatment for Hepatitis C.

Retreatment Restrictions No Restrictions

Statuses of state Medicaid restrictions are as of August 2023. Source: CHLPI and NVHR.

Sign up for HepVu updates.